Tumala, Apolinaria A.
HRN: 26-76-31 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/08/2025
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
03/08/2025
03/14/2025
IVTT
500 Mg
Q8
Intra Abdominal Infection;
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes